CVR: 39969238
Secondary names: Labogene Biotech A/S, Labogene Scientific A/S, Labogenetech A/S
DKK 15,195,981
Gross profit
Net result: DKK 1,331,395
GENE COMPANY LIMITED
CVR · view ownership and management
Director role ended: Tove Madsen
CVR · 02/09/2020
View the full event history
LABOGENE A/S is a Danish company of the type Aktieselskab based in Allerød, founded in 2018. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Mikal Skat Nørrevig. The company is owned by GENE COMPANY LIMITED. The company has 44 employees (2018). In 2025, the company reported a gross profit of DKK 15,195,981 and a net result of DKK 1,331,395 compared with DKK 1,306,291 the year before. Equity in the 2025 report amounted to DKK 18,517,822.
Source: annual report 2025, Danish Business Authority
LABOGENE A/S demonstrates a stable financial health with consistent gross profit and profitability over the past few years. Gross profit has fluctuated slightly, peaking at 17,268,881 DKK in 2021 and declining to 15,195,981 DKK in 2025, while profit figures show a notable increase in 2023 at 2,261,694 DKK before declining to 1,331,395 DKK in 2025. The company's equity has steadily grown from 12,324,227 DKK in 2021 to 18,517,822 DKK in 2025, indicating a strong equity position. Despite the lack of revenue disclosure, LABOGENE A/S maintains a solid position in the medical and dental instruments sector, showcasing resilience and potential for future growth.
AI-generated summary · Generated 15/08/2026
Selskabets formål er at drive virksomhed med salg af laboratorieudstyr til danske og internationale kunder.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 15.2 mio. | 1.3 mio. | 27.8 mio. | 18.5 mio. | 23 | |
| 202401/01/2024 – 31/12/2024 | 16.5 mio. | 1.3 mio. | 26.9 mio. | 17.2 mio. | 25 | |
| 202301/01/2023 – 31/12/2023 | 16.9 mio. | 2.3 mio. | 28.9 mio. | 15.9 mio. | 24 | |
| 202201/01/2022 – 31/12/2022 | 13.6 mio. | 1.3 mio. | 21.6 mio. | 13.6 mio. | 23 | |
| 202101/01/2021 – 31/12/2021 | 17.3 mio. | 2.9 mio. | 27.5 mio. | 12.3 mio. | 23 | |
| 202001/01/2020 – 31/12/2020 | 19.1 mio. | 4.7 mio. | 21.9 mio. | 9.4 mio. | 26 |
Compared to 309 companies in Fremstilling af medicinske og dentale instrumenter samt udstyr hertil
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationLABOGENE A/S was founded on 23 October 2018.
LABOGENE A/S is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil (industry code 325000).
LABOGENE A/S had 44 employees in 2018 according to the Danish CVR register.
LABOGENE A/S is owned by GENE COMPANY LIMITED.
labogene.com belongs to LABOGENE A/S, CVR number 39969238.
In 2025, LABOGENE A/S reported a gross profit of DKK 15,195,981.
Claim this page to add your logo and social links. Free to get started.
LABOGENE A/S has published its annual report for 2025. Gross profit came to DKK 15,195,981, and the net result was DKK 1,331,395.
LABOGENE A/S has published its annual report for 2024. Gross profit came to DKK 16,455,921, and the net result was DKK 1,306,291.
LABOGENE A/S has published its annual report for 2023. Gross profit came to DKK 16,898,260, and the net result was DKK 2,261,694.
LABOGENE A/S has published its annual report for 2022. Gross profit came to DKK 13,642,861, and the net result was DKK 1,294,215.
LABOGENE A/S has published its annual report for 2021. Gross profit came to DKK 17,268,881, and the net result was DKK 2,922,358.
As of March 1, 2022, Ching Cheung has joined the board of directors of LABOGENE A/S.
As of March 1, 2022, HUI YUK YU has left the board of directors of LABOGENE A/S.
LABOGENE A/S has published its annual report for 2020. Gross profit came to DKK 19,073,793, and the net result was DKK 4,659,695.
As of September 2, 2020, Tove Madsen has stepped down as director of LABOGENE A/S.
LABOGENE A/S has published its interim report for the period October 23, 2018 – December 31, 2019.
As of October 23, 2018, inforevision statsautoriseret revisionsaktieselskab has been appointed auditor of LABOGENE A/S.
As of October 23, 2018, Mikal Skat Nørrevig has joined the board of directors of LABOGENE A/S.
As of October 23, 2018, To CHEUNG has joined the board of directors of LABOGENE A/S.
As of October 23, 2018, Kar Yee CHEN has joined the board of directors of LABOGENE A/S.
As of October 23, 2018, Kar Chi Paul CHEN has joined the board of directors of LABOGENE A/S.
As of October 23, 2018, HUI YUK YU has joined the board of directors of LABOGENE A/S.
As of October 23, 2018, Tove Madsen is registered as director of LABOGENE A/S.
As of October 23, 2018, Mikal Skat Nørrevig is registered as director of LABOGENE A/S.
As of October 23, 2018, is registered as an owner of LABOGENE A/S with an ownership share of 100%.
LABOGENE A/S was founded on October 23, 2018.
Companies in the same industry and area
CVR 41328355
CVR 10033365
CVR 42538892
